Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10191011" target="_blank" >RIV/00216208:11110/13:10191011 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1177/1074248412471196" target="_blank" >http://dx.doi.org/10.1177/1074248412471196</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/1074248412471196" target="_blank" >10.1177/1074248412471196</a>
Alternative languages
Result language
angličtina
Original language name
Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians
Original language description
Aims: The aims of this study were (1) to explore physicians' self-reported treatment of patients with dyslipidemia and (2) to identify intercountry differences and associations between physicians' characteristics and treatment patterns. Methods: A cross-sectional survey was performed in primary health care in 9 Central and Eastern European countries. An anonymous questionnaire, which included questions devoted to dyslipidemia treatment, was distributed. Results: A total of 3000 physicians were randomlychosen and 867 responded. The mean percentage of physicians in all countries who reported regular use of statins in primary prevention of cardiovascular diseases (CVD) was 86.4 (range between 91.0% of Polish physicians and 75.7% of Czech physicians; P<.01). In secondary prevention, the mean percentage was only a little higher, 89.9. The use of fibrates for primary prevention was reported by 40.3% of the respondents from Bulgaria and by 2% of the respondents from Estonia (P<.01). Also, si
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Cardiovascular Pharmacology and Therapeutics
ISSN
1074-2484
e-ISSN
—
Volume of the periodical
18
Issue of the periodical within the volume
3
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
234-242
UT code for WoS article
000317428000007
EID of the result in the Scopus database
—